Celemics, Inc.
Founded in 2010 and listed on KOSDAQ in 2020, Celemics is an NGS-based genomic analysis technology platform company that manufactures and sells Target Capture Kits and the BTSeq next-generation sequencing solution.
As of 2026-10-10, Celemics, Inc. has 36 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureCelemics, Inc. was founded on November 29, 2010 and listed on the KOSDAQ market on August 21, 2020 as an NGS (Next Generation Sequencing)-based genomic analysis technology platform company. Based on its core next-generation cloning technology, MSSIC (Massively Separated and Sequenc Identified Cloning), the company manufactures and sells Target Capture Kit products using next-generation gene capture technology and the BTSeq next-generation sequencing solution using molecular barcode-mediated whole-sequence analysis technology. Its main business is manufacturing Target Capture kits, the core reagent for Targeted Sequencing, and providing target gene analysis services using them, operated under CEO Kim Hyo-ki with an in-house corporate research institute covering DNA materials/reagent development, optical instrument/automation equipment development, microfluidics/semiconductor processes, and bioinformatics algorithm development.
Products & technology
- Target Capture KitCore reagent for targeted sequencing using next-generation gene capture technology
- BTSeqNext-generation sequencing solution using molecular barcode-mediated whole-sequence analysis technology
Key disclosures
KRX KIND via OpenDARTPublications
PubMed · affiliation-matched- Analytical and clinical validation of CancerMaster, an automated targeted NGS panel, for tumor-only precision oncology.
Scientific reports · 2026-02 · Che J, Kwon WS, Kim J 외 9
- Development and evaluation of a hybrid capture-based NGS panel for comprehensive detection of respiratory pathogens.
Scientific reports · 2025-11 · Kim JA, Kim JM, Lee C 외 5
- Whole community and functional gene changes of biofilms on marine plastic debris in response to ocean acidification.
Microbial ecology · 2023-05 · Kerfahi D, Harvey BP, Kim H 외 3
- Spatial epitranscriptomics reveals A-to-I editome specific to cancer stem cell microniches.
Nature communications · 2022-05 · Lee AC, Lee Y, Choi A 외 30
- Identification of tissue of origin in cancer of unknown primary using a targeted bisulfite sequencing panel.
Epigenomics · 2022-05 · Bae JM, Ahn JY, Lee H 외 6
- Development and Application of a Target Capture Sequencing SNP-Genotyping Platform in Rice.
Genes · 2022-04 · Lee C, Cheon KS, Shin Y 외 12
- Circulating tumor DNA sequencing in colorectal cancer patients treated with first-line chemotherapy with anti-EGFR.
Scientific reports · 2021-08 · Lim Y, Kim S, Kang JK 외 13
- Targeted next-generation sequencing-based detection of microsatellite instability in colorectal carcinomas.
PloS one · 2021-01 · Lee Y, Lee JA, Park HE 외 8
- Development and Validation of a Next-Generation Sequencing-Based Multigene Assay to Predict the Prognosis of Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2020-12 · Lee HB, Lee SB, Kim M 외 16
- Metagenomic analysis reveals rapid development of soil biota on fresh volcanic ash.
Scientific reports · 2020-12 · Song H, Kerfahi D, Takahashi K 외 5
Show 26 more publications
- DNA Micro-Disks for the Management of DNA-Based Data Storage with Index and Write-Once-Read-Many (WORM) Memory Features.
Advanced materials (Deerfield Beach, Fla.) · 2020-09 · Choi Y, Bae HJ, Lee AC 외 10
- Cell-Free Bacteriophage Genome Synthesis Using Low-Cost Sequence-Verified Array-Synthesized Oligonucleotides.
ACS synthetic biology · 2020-06 · Yeom H, Ryu T, Lee AC 외 5
- Machine Learning-Guided Prediction of Antigen-Reactive In Silico Clonotypes Based on Changes in Clonal Abundance through Bio-Panning.
Biomolecules · 2020-03 · Yoo DK, Lee SR, Jung Y 외 7
- Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2019-10 · Lee DW, Han SW, Bae JM 외 8
- Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy.
BMC cancer · 2019-05 · Lee DW, Han SW, Cha Y 외 12
- Enzymatic construction of shRNA library from oligonucleotide library.
Genes & genomics · 2019-05 · Park SK, Kee Y, Ryu T 외 2
- High information capacity DNA-based data storage with augmented encoding characters using degenerate bases.
Scientific reports · 2019-04 · Choi Y, Ryu T, Lee AC 외 8
- High-throughput retrieval of physical DNA for NGS-identifiable clones in phage display library.
mAbs · 2019-04 · Noh J, Kim O, Jung Y 외 16
- Barcode-free next-generation sequencing error validation for ultra-rare variant detection.
Nature communications · 2019-02 · Yeom H, Lee Y, Ryu T 외 6
- Environmental filtering of bacterial functional diversity along an aridity gradient.
Scientific reports · 2019-01 · Song HK, Shi Y, Yang T 외 5
- Efficient Selection of Antibodies Reactive to Homologous Epitopes on Human and Mouse Hepatocyte Growth Factors by Next-Generation Sequencing-Based Analysis of the B Cell Repertoire.
International journal of molecular sciences · 2019-01 · Kim S, Lee H, Noh J 외 6
- From the High Arctic to the Equator: Do Soil Metagenomes Differ According to Our Expectations?
Microbial ecology · 2019-01 · Kerfahi D, Tripathi BM, Dong K 외 5
- High-throughput construction of multiple cas9 gene variants via assembly of high-depth tiled and sequence-verified oligonucleotides.
Nucleic acids research · 2018-05 · Cho N, Seo HN, Ryu T 외 9
- Bacterial strategies along nutrient and time gradients, revealed by metagenomic analysis of laboratory microcosms.
FEMS microbiology ecology · 2017-10 · Song HK, Song W, Kim M 외 4
- Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
Cancer · 2017-09 · Lee DW, Han SW, Cha Y 외 14
- Development of Soil Bacterial Communities in Volcanic Ash Microcosms in a Range of Climates.
Microbial ecology · 2017-05 · Kerfahi D, Tateno R, Takahashi K 외 3
- Effect of experimental soil disturbance and recovery on structure and function of soil community: a metagenomic and metagenetic approach.
Scientific reports · 2017-05 · Choi S, Song H, Tripathi BM 외 3
- Targeted Next-Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes.
Clinical pharmacology and therapeutics · 2017-03 · Han SM, Park J, Lee JH 외 8
- A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma.
Cold Spring Harbor molecular case studies · 2016-09 · Chen KS, Kwon WS, Kim J 외 8
- Deterministic assembly processes govern bacterial community structure in the Fynbos, South Africa.
Microbial ecology · 2016-08 · Moroenyane I, Chimphango SB, Wang J 외 2
- Predictable communities of soil bacteria in relation to nutrient concentration and successional stage in a laboratory culture experiment.
Environmental microbiology · 2016-06 · Song W, Kim M, Tripathi BM 외 2
- The impact of tropical forest logging and oil palm agriculture on the soil microbiome.
Molecular ecology · 2016-05 · Tripathi BM, Edwards DP, Mendes LW 외 4
- Microbiome Variation Across Amphibian Skin Regions: Implications for Chytridiomycosis Mitigation Efforts.
Microbial ecology · 2016-01 · Bataille A, Lee-Cruz L, Tripathi B 외 2
- Draft Genome Sequence of Caprolactam-Degrading Pseudomonas putida Strain SJ3.
Genome announcements · 2015-07 · Hong SJ, Park GS, Khan AR 외 6
- A high-throughput optomechanical retrieval method for sequence-verified clonal DNA from the NGS platform.
Nature communications · 2015-02 · Lee H, Kim H, Kim S 외 4
- Effects of functionalized and raw multi-walled carbon nanotubes on soil bacterial community composition.
PloS one · 2015-01 · Kerfahi D, Tripathi BM, Singh D 외 4
Patents
KIPRIS · applicant-matchedPublished · 2024-05 · Application 1020240058850
Published · 2023-11 · Application 1020230158791
Registered · 2023-05 · Application 1020230064832
Registered · 2022-04 · Application 1020220044362
PCT · Published · 2022-04 · Application PCT/KR2022/005202
Registered · 2021-04 · Application 1020210052845
Rejected · 2020-10 · Application 1020200136479
PCT · Published · 2019-10 · Application PCT/KR2019/014243
PCT · Published · 2019-10 · Application PCT/KR2019/014241
PCT · Published · 2019-03 · Application PCT/KR2019/002634
Show 38 more patents
CN · Published · 2019-02 · Application 201980012454.1
Registered · 2019-02 · Application 1020190015072
PCT · Published · 2019-02 · Application PCT/KR2019/001588
Rejected · 2018-11 · Application 1020180137665
Rejected · 2018-11 · Application 1020180137666
CN · Published · 2018-10 · Application 201880069628.3
US · Published · 2018-10 · Application 16754975
PCT · Published · 2018-10 · Application PCT/KR2018/012146
Registered · 2018-08 · Application 1020180092240
Rejected · 2018-07 · Application 1020180078052
Rejected · 2018-07 · Application 1020180078054
Rejected · 2018-07 · Application 1020180078047
Registered · 2018-05 · Application 1020180051375
CN · Published · 2018-02 · Application 201880012969.7
US · Published · 2018-02 · Application 16486668
PCT · Published · 2018-02 · Application PCT/KR2018/002049
Registered · 2017-10 · Application 1020170140064
Registered · 2017-10 · Application 1020170136293
PCT · Published · 2017-10 · Application PCT/KR2017/011606
US · Published · 2017-05 · Application 16304341
PCT · Published · 2017-05 · Application PCT/KR2017/005455
Rejected · 2017-05 · Application 1020170063294
Registered · 2017-02 · Application 1020170022167
CN · Published · 2016-11 · Application 201680063982.6
Registered · 2016-11 · Application 1020160147000
US · Published · 2016-11 · Application 15772865
EP · Registered · 2016-11 · Application 16862499.7
PCT · Published · 2016-11 · Application PCT/KR2016/012699
US · Registered · 2016-04 · Application 15132245
Expired · 2015-11 · Application 2020150007486
Registered · 2015-10 · Application 1020150139630
Registered · 2013-12 · Application 1020130155241
CN · Published · 2013-12 · Application 201380064845
Registered · 2013-12 · Application 1020130154187
Registered · 2013-12 · Application 1020130154186
US · Registered · 2013-12 · Application 14650871
EP · Registered · 2013-12 · Application 13863345.8
Registered · 2012-08 · Application 1020120084303
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIOAI-SearchBot30
- MicrosoftBingbot2
- AnthropicClaudeBot2
- GoogleGoogleOther1
- PerplexityPerplexityBot1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Celemics, Inc. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies in the same categoryPharma & CDMO
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.
Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition